The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.
A project that began as a Gates Foundation-funded effort to expand contraceptive options, particularly in developing nations, has led to the development of a new method to deliver certain drugs in ...
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the ...
Long-awaited glucagon-like peptide-1 agonist (GLP-1) tablets don’t appear to be stealing significant market share from GLP-1 injectables. Rather, industry experts told MD+DI that they expect ...
Bags of IV drugs distributed nationwide are being recalled for being mislabeled as a lesser-dose than what the drugs actually are, increasing the risk for overdosing and even death, according to the ...
MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a suspension of tiny crystals. Once under the skin, the crystals assemble into a drug ...
China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.
Long-acting injectable formulations are designed to maintain therapeutic drug concentrations over extended periods—from weeks to months—following a single administration. By forming a depot at the ...
Reports of poisoning tied to injectable weight-loss drugs in the Netherlands doubled to 149 in 2025 from 76 a year earlier, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results